A detailed history of Cardinal Capital Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cardinal Capital Management, Inc. holds 20,248 shares of GILD stock, worth $1.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
20,248
Previous 190,383 89.36%
Holding current value
$1.9 Million
Previous $13.1 Million 87.01%
% of portfolio
0.08%
Previous 0.61%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$66.59 - $83.99 $11.3 Million - $14.3 Million
-170,135 Reduced 89.36%
20,248 $1.7 Million
Q2 2024

Jul 08, 2024

BUY
$63.15 - $72.88 $73,443 - $84,759
1,163 Added 0.61%
190,383 $13.1 Million
Q1 2024

Apr 09, 2024

BUY
$71.58 - $87.29 $639,209 - $779,499
8,930 Added 4.95%
189,220 $13.9 Million
Q4 2023

Feb 23, 2024

SELL
$73.27 - $83.09 $174,748 - $198,169
-2,385 Reduced 1.31%
180,290 $14.6 Million
Q3 2023

Oct 12, 2023

BUY
$73.94 - $80.67 $41,036 - $44,771
555 Added 0.3%
182,675 $13.7 Million
Q2 2023

Jul 10, 2023

SELL
$76.01 - $86.7 $124,276 - $141,754
-1,635 Reduced 0.89%
182,120 $14 Million
Q1 2023

Apr 06, 2023

SELL
$77.31 - $88.08 $120,217 - $136,964
-1,555 Reduced 0.84%
183,755 $15.2 Million
Q4 2022

Feb 02, 2023

BUY
$62.32 - $89.47 $274,831 - $394,562
4,410 Added 2.44%
185,310 $15.9 Million
Q3 2022

Oct 07, 2022

BUY
$59.54 - $68.01 $259,594 - $296,523
4,360 Added 2.47%
180,900 $11.2 Million
Q2 2022

Jul 13, 2022

SELL
$57.72 - $65.01 $5.18 Million - $5.84 Million
-89,830 Reduced 33.72%
176,540 $10.9 Million
Q1 2022

Apr 12, 2022

BUY
$57.92 - $72.58 $1.4 Million - $1.76 Million
24,230 Added 10.01%
266,370 $15.8 Million
Q4 2021

Jan 19, 2022

BUY
$64.88 - $73.64 $1.08 Million - $1.22 Million
16,600 Added 7.36%
242,140 $17.6 Million
Q3 2021

Oct 07, 2021

BUY
$67.69 - $73.03 $565,888 - $610,530
8,360 Added 3.85%
225,540 $15.8 Million
Q2 2021

Jul 09, 2021

BUY
$63.47 - $69.35 $1.24 Million - $1.35 Million
19,537 Added 9.88%
217,180 $15 Million
Q1 2021

Apr 14, 2021

BUY
$60.0 - $68.46 $2.44 Million - $2.79 Million
40,708 Added 25.94%
197,643 $12.8 Million
Q4 2020

Jan 15, 2021

BUY
$56.65 - $64.55 $701,610 - $799,451
12,385 Added 8.57%
156,935 $9.14 Million
Q3 2020

Oct 13, 2020

BUY
$62.1 - $78.08 $1.34 Million - $1.69 Million
21,645 Added 17.61%
144,550 $9.13 Million
Q2 2020

Jul 08, 2020

BUY
$72.34 - $84.0 $1.77 Million - $2.06 Million
24,500 Added 24.9%
122,905 $9.46 Million
Q1 2020

Apr 08, 2020

BUY
$62.63 - $80.22 $6.16 Million - $7.89 Million
98,405 New
98,405 $7.36 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cardinal Capital Management, Inc. Portfolio

Follow Cardinal Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management, Inc. with notifications on news.